Southeast Nebraska Oncology Cancer Center — Lincoln, Nebraska

Southeast Nebraska Oncology Cancer Center is a clinical research site located in Lincoln, Nebraska, United States 68510.

Crixeo Health Trust Score: 65/100 (FAIR). This profile has not yet been claimed by the site owner.

Southeast Nebraska Oncology Cancer Center has participated in 4 clinical trials.

Therapeutic areas: Breast Cancer, Tumor Pathway Activations Inhibited by Dovitinib, First or Second Line HER2-negative Breast Cancer.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 65/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Southeast Nebraska Oncology Cancer Center?

Southeast Nebraska Oncology Cancer Center has a Crixeo Trust Score of 65/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Southeast Nebraska Oncology Cancer Center conducted?

Southeast Nebraska Oncology Cancer Center has 4 clinical trials on record. Their work covers Breast Cancer, Tumor Pathway Activations Inhibited by Dovitinib, First or Second Line HER2-negative Breast Cancer.

Is Southeast Nebraska Oncology Cancer Center accredited by Crixeo Health?

Southeast Nebraska Oncology Cancer Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Southeast Nebraska Oncology Cancer Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.